Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
The earnings call summary presents a mixed picture: while there are positive developments in product development, market strategy, and shareholder returns, concerns about expenses and financial health persist. The Q&A section reveals some uncertainties, particularly regarding pricing and future collaborations, which tempers the overall sentiment. The absence of clear guidance on certain aspects and the unchanged CapEx budget suggest a cautious outlook. Given these factors, the stock price reaction is likely to be neutral, with no significant catalysts to drive a strong movement in either direction.
Consolidated Revenue (Q4 2025) TWD 61.81 billion, a 4.5% quarter-over-quarter increase supported by favorable foreign exchange movements and growth in the 22- and 28-nanometer business.
Gross Margin (Q4 2025) 30.7%, an improvement from the previous quarter due to better product mix and increased revenue from 22- and 28-nanometer segments.
Net Income Attributable to Stockholders (Q4 2025) TWD 10.06 billion, with an EPS of TWD 0.81, similar to the previous quarter.
Revenue (Full Year 2025) TWD 237.5 billion, a 2.3% year-over-year increase driven by a 12.3% increase in shipments and a 5.3% revenue growth in U.S. dollars.
Gross Margin (Full Year 2025) 29% or TWD 68.9 billion, reflecting stable performance.
Net Income Attributable to Stockholders (Full Year 2025) TWD 41.7 billion, with a net income rate of 17.6% and an EPS of TWD 3.34, a decline from TWD 3.8 in 2024 due to unspecified factors.
Cash Balance (End of 2025) More than TWD 110 billion, indicating strong liquidity.
Revenue Contribution from 22- and 28-Nanometer Segments (Q4 2025) 36% of total revenue, with 22-nanometer revenue increasing 31% quarter-over-quarter to a record high of 13% of total Q4 revenue.
Revenue Contribution from Consumer Applications (Full Year 2025) 31%, a 3 percentage point increase from 28% in 2024.
22-nanometer and 28-nanometer technology: Revenue from 22-nanometer technology increased 31% quarter-on-quarter to a record high, accounting for more than 13% of total Q4 revenue. These technologies represented 36% of total revenue in Q4 2025 and are key drivers of growth.
Advanced packaging and silicon photonics: Identified as new growth catalysts to address high-performance applications across AI, networking, consumer, and automotive sectors.
Singapore Fab 12i Phase III: Completed in 2025, this facility supports customers in diversifying their supply chain.
U.S. market expansion: Expanding footprint through partnerships, including a 12-nanometer collaboration with Intel and an MoU with Polar Semiconductor.
Capacity and utilization: Capacity remained flat quarter-over-quarter but will decline by 1% due to annual maintenance. Utilization rate in Q4 2025 was around 78%.
CapEx: 2026 CapEx budget is USD 1.5 billion, slightly down from USD 1.6 billion in 2025.
Specialty technologies: Leadership in embedded High Voltage, Non-Volatile Memory, and BCD technologies is expected to sustain stable business growth.
Revenue dependency on 22- and 28-nanometer segments: UMC's growth is heavily reliant on the 22- and 28-nanometer segments, which accounted for 36% of total revenue in Q4 2025. Any market downturn or technological obsolescence in these segments could significantly impact revenue.
Geographic revenue shifts: Revenue from North America dropped from 25% in 2024 to 22% in 2025, indicating potential challenges in maintaining market share in this critical region.
Capacity utilization: Capacity utilization rate is expected to remain in the mid-70% range for Q1 2026, which is relatively low and could indicate inefficiencies or underutilization of resources.
CapEx reduction: The 2026 CapEx plan is reduced to USD 1.5 billion from USD 1.6 billion in 2025, which may limit future growth opportunities or technological advancements.
Economic and market demand uncertainties: Mild demand across most markets and reliance on favorable foreign exchange movements for revenue growth highlight vulnerabilities to economic and market fluctuations.
Supply chain diversification: While UMC is diversifying its supply chain with new facilities and partnerships, any delays or inefficiencies in these initiatives could disrupt operations and customer relationships.
Wafer Demand: UMC expects wafer demand to remain firm in the first quarter of 2026.
Revenue Growth: UMC is confident that 2026 will be another growth year, driven by accelerated tape-out on the 22-nanometer platform and new solutions gaining business traction.
Capital Expenditures: The 2026 CapEx plan is forecasted at USD 1.5 billion, slightly down from USD 1.6 billion in 2025.
Gross Margin: Gross margin for the first quarter of 2026 is expected to be in the high 20% range.
Capacity Utilization: Capacity utilization rate is projected to be in the mid-70% range for the first quarter of 2026.
Advanced Packaging and Silicon Photonics: UMC anticipates advanced packaging and silicon photonics to serve as new growth catalysts, addressing high-performance applications across AI, networking, consumer, and automotive sectors.
22- and 28-Nanometer Business: The 22- and 28-nanometer segment continues to be a key growth driver, with 22-nanometer revenue increasing 31% quarter-on-quarter in Q4 2025 and expected to accelerate further in 2026.
The selected topic was not discussed during the call.
The earnings call summary presents a mixed picture: while there are positive developments in product development, market strategy, and shareholder returns, concerns about expenses and financial health persist. The Q&A section reveals some uncertainties, particularly regarding pricing and future collaborations, which tempers the overall sentiment. The absence of clear guidance on certain aspects and the unchanged CapEx budget suggest a cautious outlook. Given these factors, the stock price reaction is likely to be neutral, with no significant catalysts to drive a strong movement in either direction.
The earnings call presents a mixed outlook: while there are positive developments such as expected growth in wafer shipments and strategic expansions, there are concerns over foreign exchange impacts, flat gross margins, and geopolitical uncertainties. The Q&A reveals management's cautious stance on specific forecasts and cost pressures. While there are no strong negative indicators, the lack of clear guidance and the mixed financial outlook suggest a neutral sentiment, likely leading to minimal stock movement.
The earnings call summary shows strong revenue growth in key technology nodes, cost reduction plans, and optimistic guidance on wafer shipment and gross margins. The Q&A section indicates a focus on technology development and strategic partnerships, with positive analyst sentiment. Despite some uncertainties, the overall outlook is optimistic, with potential for stock price appreciation over the next two weeks.
The earnings call presents a mixed picture: revenue and wafer shipments increased, but net income and gross margin declined. The Q&A section reveals limited visibility on future demand and cautious customer behavior. The proposed dividend and stable cash position are positives, but the lack of clear guidance on tariffs and margins, coupled with a significant drop in net income, temper enthusiasm. The stable CapEx and ongoing Intel collaboration are promising, but the overall sentiment remains cautious. Without strong catalysts, the stock is likely to remain neutral in the short term.
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.